Weaver C. Barksdale & Associates’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2K Buy
86
+29
+51% +$577 ﹤0.01% 450
2017
Q3
$1K Buy
+57
New +$1.29K ﹤0.01% 465

Other funds holding SBRA

Weaver C. Barksdale & Associates's SBRA Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Sabra Healthcare REIT (SBRA) stake by 51% in Q4 2017, buying an estimated $577 and bringing the position to 86 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Weaver C. Barksdale & Associates first reported a position in SBRA in Q3 2017 and has held it in 2 quarters since. 332 funds tracked by Wall St. Rank hold SBRA as of Q4 2017.

  • Weaver C. Barksdale & Associates held 86 shares of Sabra Healthcare REIT worth $2K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 29 Sabra Healthcare REIT shares in Q4 2017, an estimated $577.
  • Sabra Healthcare REIT made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #450 holding.
  • Weaver C. Barksdale & Associates first reported a position in Sabra Healthcare REIT in Q3 2017 and has held it in 2 quarters since.
  • 332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.